RxDoctor Payments Data

William Mauntel, MD

Family Medicine · Fairfield, OHNPI 1780673129

Payments from drug & device makers

$310in general payments, 2019–2025

Across 20 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$48
  • Amarin Pharma, Inc.$35
  • AbbVie$32
  • Novo Nordisk$31
  • Johnson & Johnson$23
  • Amgen$23
  • plus $118 from 8 others

What the payments were for

  • Food & beverage$310100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$310 in reported general payments places this provider in the 45th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$109,802
Medicare patients
271
Services billed
1,258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate103$129,472
JardianceEmpagliflozin84$99,321
EliquisApixaban114$90,203
OzempicSemaglutide55$78,017
MounjaroTirzepatide65$72,524
RybelsusSemaglutide35$62,139
FarxigaDapagliflozin Propanediol41$45,117
XareltoRivaroxaban33$41,982
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$31,547
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$17,606
Lantus SolostarInsulin Glargine,hum.Rec.Anlog90$15,572
Advair HfaFluticasone Propion/Salmeterol12$12,070
LinzessLinaclotide16$11,147
Breo ElliptaFluticasone/Vilanterol12$8,880
Atorvastatin Calcium771$6,669

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$31$140,15690 claims
PfizerEliquis$48$90,203114 claims
AstraZenecaFarxiga$14$45,11741 claims
Johnson & JohnsonXarelto$23$41,98233 claims
GSKTrelegy Ellipta, Breo Ellipta$17$40,42644 claims
AbbVieLinzess, Synthroid$32$13,00290 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Fairfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →